awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53786874-08F97BA2-D44F-408F-8A69-EA2892C06177
Q53786874-08F97BA2-D44F-408F-8A69-EA2892C06177
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53786874-08F97BA2-D44F-408F-8A69-EA2892C06177
Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer.
P2093
Q53786874-08F97BA2-D44F-408F-8A69-EA2892C06177
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53786874-08F97BA2-D44F-408F-8A69-EA2892C06177
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4006e33c123a1e51bc423945fd78baf8d6f6d9c4
P1545
5
http://www.w3.org/2001/XMLSchema#string
P2093
Tarek Assi
http://www.w3.org/2001/XMLSchema#string